Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

Targeted therapies in endometrial cancer (EC) using kinase inhibitors rarely result in complete tumor remission and are frequently challenged by the appearance of refractory cell clones, eventually resulting in disease relapse. Dissecting adaptive mechanisms is of vital importance to circumvent clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Eritja, Núria, Chen, Bo-Juen, Rodríguez-Barrueco, Ruth, Santacana, Maria, Gatius, Sònia, Vidal, August, Martí, Maria Dolores, Ponce, Jordi, Bergadà, Laura, Yeramian, Andree, Encinas, Mario, Ribera, Joan, Reventós, Jaume, Boyd, Jeff, Villanueva, Alberto, Matias-Guiu, Xavier, Dolcet, Xavier, Llobet-Navàs, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361596/
https://www.ncbi.nlm.nih.gov/pubmed/28055301
http://dx.doi.org/10.1080/15548627.2016.1271512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361596/
https://www.ncbi.nlm.nih.gov/pubmed/28055301
http://dx.doi.org/10.1080/15548627.2016.1271512

Ejemplares similares